Spinal cord stimulation for gait in Parkinsons disease in subthreshold settings
Objective: To assess optimal parameters for tonic spinal cord stimulation (SCS) for Parkinson’s Disease (PD) gait disorders in blinded settings. Background: SCS is a promising…Associations of IL-1β and IL-6 gene polymorphisms with Parkinson’s disease(PD)
Objective: We aim to explore the associations of IL-1β and IL-6 gene polymorphisms with the pathogenesis of PD and with clinical features of motor and…Efficacy and safety of safinamide in PD patients over 70 years vs. under 70 years old;
Objective: To search for any differences between efficacy and safety of safinamide in PD patients over 70 years vs. under 70 years old. Background: Safinamide…The specific application of a motor rehabilitation package in correcting the psycho-emotional sphere in patients with Parkinson’s disease.
Objective: The study aimed to investigate the effectiveness of a motor rehabilitation programme for 48 patients with Parkinson's disease using the phenomenon of paradoxical kinesia…Evidence of Central Autonomic Network dysfunction in orthostatic hypotension of Parkinson’s disease
Objective: To examine the contribution of the central autonomic network (CAN) to physiologic evidence of autonomic failure in Parkinson’s disease (PD). Background: Autonomic dysfunction, particularly…Implementation and effects of telehealth exercise therapy on satisfaction and Mobility In persons with Parkinson’s.
Objective: To improve PD care and motor performance using telehealth exercise therapy in individuals with PD. Background: Parkinson’s disease (PD) is a chronic disease with…Detection of Camptocormia Using Ultrasound in Parkinson’s Disease
Objective: To investigate whether changes in the lumbar paravertebral muscles (LPM) can be detected using muscle ultrasonography (USG) in patients with Parkinson’s disease (PD, PwP)…Efficacy of melatonin in patients with insomnia and Parkinson’s disease
Objective: Determine the efficacy of melatonin in patients with Parkinson's disease suffering from insomnia. Background: Parkinson disease (PD) is a degenerative disease manifested by motor…Safety of foslevodopa/foscarbidopa during optimization and maintenance treatment: Post hoc analysis of a phase 3, single-arm trial
Objective: Evaluate the frequency of adverse events over time with foslevodopa/foscarbidopa (LDP/CDP) in patients with advanced Parkinson’s disease (PD) in a phase 3, open-label safety…The long and short of contemporary parkinsonism survival: A 47-year clinicopathological study
Objective: We report a 47-year survival study of autopsy verified Parkinson syndrome (PS) and Parkinson’s disease (PD) cases. The objectives were: 1) to identify PS…
- « Previous Page
- 1
- …
- 184
- 185
- 186
- 187
- 188
- …
- 338
- Next Page »